Skip to main content
Jeffrey Sobell, MD, Dermatology, Chestnut Hill, MA

JeffreyMichaelSobellMD

Dermatology Chestnut Hill, MA

Associate Professor, Dermatology, Tufts Medical Center

Dr. Sobell is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Sobell's full profile

Already have an account?

  • Office

    1244 Boylston St
    Suite 302
    Chestnut Hill, MA 02467
    Phone+1 617-731-1600
    Fax+1 617-731-1601

Summary

  • Dr. Jeffrey Sobell is a dermatologist in Chestnut Hill, MA and is affiliated with multiple hospitals in the area, including Tufts Medical Center, New England Baptist Hospital, and MelroseWakefield Healthcare. He received his medical degree from University of Virginia School of Medicine and has been in practice 24 years. He is experienced in general dermatology, psoriasis, blistering diseases, and complex medical dermatology. He has more than 20 publications and over 500 citings.

Education & Training

  • Boston University Medical Center
    Boston University Medical CenterResidency, Dermatology, 1994 - 1997
  • University of Virginia Medical Center
    University of Virginia Medical CenterInternship, Internal Medicine, 1993 - 1994
  • University of Virginia School of Medicine
    University of Virginia School of MedicineClass of 1993

Certifications & Licensure

  • MA State Medical License
    MA State Medical License 1997 - 2025
  • American Board of Dermatology Dermatology

Awards, Honors, & Recognition

  • Boston Magazine Castle Connolly, 2010-2013
  • Fellow (FAAD) American Academy of Dermatology

Publications & Presentations

PubMed

Press Mentions

  • Pearls to Optimize Safety, Success with Biologics
    Pearls to Optimize Safety, Success with BiologicsDecember 5th, 2016
  • OTEZLA® (Apremilast) Mantiene El Perfil De Seguridad a Largo Plazo en El Tratamiento De Psoriasis Y Artritis Psoriásica, Según Nuevos Datos
    OTEZLA® (Apremilast) Mantiene El Perfil De Seguridad a Largo Plazo en El Tratamiento De Psoriasis Y Artritis Psoriásica, Según Nuevos DatosMarch 11th, 2016
  • Oral OTEZLA® (Apremilast) Long-Term Safety Data Presented at American Academy of Dermatology Congress
    Oral OTEZLA® (Apremilast) Long-Term Safety Data Presented at American Academy of Dermatology CongressMarch 7th, 2016
  • Join now to see all

Professional Memberships